FDA patient, consumer reps often tied to pharma-funded groups
Patient and consumer representatives advising U.S. Food and Drug Administration (FDA) expert panels might actually be a Trojan horse for the pharmaceutical industry, a new study says.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Accelerated TMS cuts depression treatment time from six weeks to three
United Kingdom
-
Inspire device offers new sleep apnea treatment for teens with Down syndrome
United Kingdom
-
Southampton scientists explore immune cell reprogramming to fight common viruses
United Kingdom
-
AI-powered eye tracking could personalize virtual reality therapy for chronic pain
United Kingdom
-
Tenant right-to-counsel program may reduce emergency visits among high-risk populations
United Kingdom
-
Global study aims to map brain changes across eight psychiatric disorders
United Kingdom
-
Prenatal iron deficiency linked to lasting changes in the offspring brain
United Kingdom
-
Study identifies blood proteins associated with aggressive prostate cancer risk
United Kingdom